Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Atherosclerosis. Supplements|January 30, 2013
Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous systemCarlo AntozziGiornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Plasmapheresis in central nervous system disorders]Carlo AntozziExpert Opinion on Biological Therapy|September 29, 2025
An evaluation of nipocalimab for the treatment of generalized myasthenia gravisCarlo Antozzi, Marie FitzgibbonFrontiers in Neurology|September 28, 2020
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for ResearchRenato Mantegazza, Carlo AntozziTherapeutic Advances in Neurological Disorders|February 7, 2018
When myasthenia gravis is deemed refractory: clinical signposts and treatment strategiesRenato Mantegazza, Carlo AntozziPatient Related Outcome Measures|October 25, 2023
Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia GravisCarlo Antozzi, Renato MantegazzaFrontiers in Immunology|June 21, 2024
Targeting autoimmune mechanisms by precision medicine in Myasthenia GravisPaola Cavalcante, Renato Mantegazza, Carlo AntozziNeuropsychiatric Disease and Treatment|May 10, 2011
Current and emerging therapies for the treatment of myasthenia gravisRenato Mantegazza, Silvia Bonanno, Giorgia Camera, et al.Archivum Immunologiae Et Therapiae Experimentalis|December 14, 2011
Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?Fulvio Baggi, Carlo Antozzi, Chiara Toscani, et al.Annals of the New York Academy of Sciences|December 21, 2012
Patient registries: useful tools for clinical research in myasthenia gravisFulvio Baggi, Renato Mantegazza, Carlo Antozzi, et al.Pageof 9